Retour
Prix Nykode Therapeutics AS (VACBF)
Graphique du cours de l'action VACBF
VACBF Dividendes
Nykode Therapeutics AS
$0.31
0%
$0
À la fermeture : Jan 27, 16:00:00 GMT-5
$0.31
0%
$0
Pré-Marché: Jan 28, 08:24:15 GMT-5
Nykode Therapeutics AS Informations sur les dividendesHistorique des dividendes Graphiques des dividendes
VACBF Dividendes
VACBF Croissance des dividendes (variation annuelle)
Follow-Up Questions
Quel est le dividende actuel payé par Nykode Therapeutics AS et son dividende annuel ?
Quel est le ratio de distribution de dividendes de Nykode Therapeutics AS ?
Quelle est la date ex-dividende pour VACBF ?
À quelle fréquence Nykode Therapeutics AS verse-t-elle des dividendes ?
Statistiques clés
Clôture préc.
$0.31
Prix d'ouverture
$0.31
Plage de la journée
$0.31 - $0.31
Plage de 52 semaines
$0.1557 - $0.31
Volume
10.0K
Volume moyen
166
BPA (TTM)
-0.03
Rendement en dividend
--
Capitalisation boursière
$101.2M
Qu’est-ce que NYKODE THERAPEUTICS ASA ?
Nykode Therapeutics ASA is a clinical-stage biopharmaceutical company which engages in discovering and developing of novel immunotherapies. The company is headquartered in Oslo, Oslo and currently employs 62 full-time employees. The company went IPO on 2020-01-27. Nykode uses its vaccine technology platform to generate therapeutics in disease indications with unmet medical need. The firm develops next generation vaccines for clinical use, based on a deep understanding of immunological principles. Nykode Therapeutics’ main product candidates are VB10.16 and VB10.NEO. VB10.16 is a therapeutic cancer vaccine against HPV16-related cancers. VB10. NEO is a therapeutic cancer neoantigen vaccine. The firm also has two universal COVID-19 vaccine candidates in development.
Fonctionnalités
Stratégies de trading
Ressources
© 2025 Finture Development Limited. All rights reserved